STOCK TITAN

Hercules Capital, Inc. Form 4 Filings

HTGC NYSE

Every Form 4 that Hercules Capital, Inc. (HTGC) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow HTGC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HTGC filings page.

Rhea-AI Summary

Hercules Capital, Inc. (HCXY) reported that President Seth H. Meyer had 5 shares of common stock disposed of on September 9, 2026 in a transaction reported as shares delivered or withheld for payment of tax liability related to vesting of restricted stock. Following this tax-withholding event, he directly holds 435,600 shares of Hercules Capital common stock.

Rhea-AI Summary

Hercules Capital, Inc. Chief Operating Officer Christian Follmann reported compensation-related equity activity in Common Stock. On July 9, 2026, a total of 2,798 shares were surrendered in two tax-withholding dispositions at $15.69 per share to cover taxes on the vesting of restricted stock, rather than being sold in the open market. Following these transactions, Follmann holds 144,539 shares directly and 350 shares indirectly through his spouse.

Rhea-AI Summary

Hercules Capital, Inc. president Seth H. Meyer reported two Form 4 transactions involving common stock on July 9, 2026. A total of 6,469 shares were disposed of at $15.69 per share as tax-withholding dispositions to cover taxes on the vesting of restricted stock. These were not open-market sales. After the transactions, Meyer continued to hold over 435,000 shares of Hercules Capital common stock directly.

Rhea-AI Summary

Hercules Capital, Inc. Chief Executive Officer Scott Bluestein reported two Form 4 transactions involving the company’s common stock on July 9, 2026. In both cases, shares were disposed of under code F, which reflects shares withheld to cover tax obligations rather than open-market sales.

The transactions relate to the vesting of restricted stock, with an aggregate of 20,393 shares of common stock withheld at a reference price of $15.69 per share to pay applicable taxes. After these tax-withholding dispositions, Bluestein continues to hold a direct ownership position of more than 2.4 million shares of Hercules Capital common stock.

Rhea-AI Summary

Hercules Capital, Inc. officer Kiersten Zaza Botelho, Chief Legal Officer & CCO, reported two tax-withholding dispositions of common stock on July 9, 2026. A total of 1,974 shares were withheld at $15.69 per share to cover taxes on vesting restricted stock, with substantial share ownership reported remaining afterward.

Rhea-AI Summary

BADAVAS ROBERT P reported acquisition or exercise transactions in this Form 4 filing.

Hercules Capital director Robert P. Badavas reported updated holdings and a new share grant. He received 3,873 shares of common stock as a restricted stock award at $15.49 per share, issued automatically upon his re-election to the board under the 2026 Non-Employee Director Plan. Following this grant, he directly holds 8,943 shares, and a trust identified as the Robert P. Badavas Trust of 2007 holds 122,073 shares indirectly. The restricted stock is subject to forfeiture, with one-third vesting on each anniversary of the grant over three years.

Rhea-AI Summary

BADAVAS ROBERT P reported acquisition or exercise transactions in this Form 4 filing.

Hercules Capital director Robert P. Badavas reported an equity award and updated holdings. He received 3,873 shares of restricted common stock on June 18, 2026 at $15.49 per share as an automatic grant upon re-election to the board under the 2026 Non-Employee Director Plan. These shares are subject to forfeiture, with one-third vesting on each anniversary of the grant over three years. After this award, he directly holds 8,943 shares of common stock and indirectly holds 122,073 shares through the Robert P. Badavas Trust of 2007.

Rhea-AI Summary

BADAVAS ROBERT P reported acquisition or exercise transactions in this Form 4 filing.

Hercules Capital director Robert P. Badavas reported new equity compensation and updated holdings. He received 3,873 shares of restricted common stock at $15.49 per share as an automatic grant upon re-election to the board under the 2026 Non-Employee Director Plan. These restricted shares are subject to forfeiture, with one-third vesting on each anniversary of the grant over three years, and bring his directly held common stock to 8,943 shares. In addition, 122,073 shares of common stock are held indirectly by the Robert P. Badavas Trust of 2007.

Rhea-AI Summary

BADAVAS ROBERT P reported acquisition or exercise transactions in this Form 4 filing.

Hercules Capital director Robert P. Badavas received a grant of 3,873 shares of common stock as restricted stock. The award was issued automatically upon his re-election to the board under the 2026 Non-Employee Director Plan at a reference price of $15.49 per share.

Following the grant, Badavas holds 8,943 shares directly and 122,073 shares indirectly through the Robert P. Badavas Trust of 2007. The restricted stock is subject to forfeiture, with one-third scheduled to vest on each anniversary of the grant over three years, reflecting routine equity-based director compensation rather than an open-market purchase.

Rhea-AI Summary

Hercules Capital Chief Financial Officer Seth H. Meyer reported a small tax-related share disposition. On June 9, 2026, 5 shares of common stock were withheld at $15.45 per share to cover taxes upon the vesting of restricted stock. After this routine tax withholding, he directly holds 442,074 shares of Hercules Capital common stock.

Rhea-AI Summary

Hercules Capital, Inc. Chief Legal Officer & CCO Kiersten Zaza Botelho reported routine tax-related share dispositions connected to vesting of restricted stock. On April 9, shares of common stock totaling 1,974 were withheld by the company to cover applicable taxes at a reference price of $14.74 per share. After these withholding transactions, she directly holds 91,362 shares of Hercules Capital common stock.

Rhea-AI Summary

Hercules Capital, Inc. Chief Operating Officer Christian Follmann reported routine share dispositions related to tax withholding on vested equity. On April 9, 2026, a total of 2,798 shares of common stock were withheld at $14.74 per share to cover taxes on restricted stock vesting.

After these tax-withholding dispositions, Follmann held 148,770 shares of Hercules Capital common stock directly. He also reported indirect ownership of 350 additional shares held by his spouse. The filing reflects compensation-related tax settlements rather than open-market stock sales.

Rhea-AI Summary

Hercules Capital, Inc. Chief Financial Officer Seth H. Meyer reported routine share withholdings tied to equity compensation. On April 9, 2026, a total of 6,469 shares of common stock were withheld as a tax-withholding disposition at $14.74 per share to cover taxes on vesting restricted stock. Following these non‑market transactions, Meyer directly holds 442,079 shares of Hercules Capital common stock.

Rhea-AI Summary

Hercules Capital, Inc. Chief Executive Officer Scott Bluestein reported routine tax-related share withholdings tied to restricted stock vesting. On April 9, 2026, a total of 20,393 shares of common stock were withheld at $14.74 per share to cover applicable taxes. After these transactions, he directly holds 2,495,986 shares of Hercules Capital common stock.

Rhea-AI Summary

BADAVAS ROBERT P reported open-market purchase transactions in this Form 4 filing.

Hercules Capital director Robert P. Badavas acquired 3,658 shares of common stock at an average price of $14.35 per share. The shares were taken as stock in lieu of a cash director compensation fee. Following this transaction, he holds 5,070 shares directly and 122,073 shares indirectly through the Robert P. Badavas Trust of 2007.

Rhea-AI Summary

Hercules Capital director Wade Loo acquired 7,317 shares of common stock through an open-market purchase, electing to receive stock in lieu of a director cash compensation fee at an average price of $14.35 per share. After this transaction, he holds 14,050 shares directly, including shares acquired through the company’s dividend reinvestment plan, and 32,767 shares indirectly through the Loo Revocable Trust.

Rhea-AI Summary

Hercules Capital director Thomas J. Fallon increased his stake through equity compensation rather than cash. On March 26, 2026, a trust associated with him acquired 7,300 shares of Hercules Capital common stock at $14.30 per share, reported as an open‑market purchase.

The footnotes explain these shares were received in lieu of a cash director fee and are held by the Fallon Family Revocable Trust. After this transaction, the trust held 157,669 shares, while Fallon also reported 5,959 shares held directly, including shares accumulated through the company’s dividend reinvestment plan.

Rhea-AI Summary

Hercules Capital, Inc. director DeAnne Aguirre acquired common stock by electing to receive shares instead of a cash director fee. She obtained 7,317 shares at an average price of $14.35 per share, with actual purchase prices ranging from $14.31 to $14.39.

Following this compensation-related acquisition, she directly holds 10,749 shares of common stock. In addition, 20,086 shares are held indirectly by the Aguirre Family 2004 Trust. The filing notes that the share count includes stock acquired through Hercules Capital’s dividend reinvestment plan under Rule 16a-11.

Rhea-AI Summary

Hercules Capital, Inc. director Paramjeet K. Randhawa acquired 2,926 shares of common stock on March 26, 2026 through an open-market purchase at an average price of $14.35 per share. Following this transaction, the director directly holds 22,486 shares of Hercules Capital common stock.

According to the footnotes, the shares were purchased based on the director’s election to receive stock in lieu of a cash compensation fee otherwise payable for board service. The average purchase price reflects trades executed in a price range between $14.31 and $14.39 per share.

Rhea-AI Summary

Hercules Capital director Gayle A. Crowell acquired 7,317 shares of Common Stock through an open-market purchase election on March 26, 2026 at an average price of $14.35 per share. These shares were received in stock instead of a cash director fee.

After this transaction, Crowell directly holds 97,589 Hercules Capital shares. The filing notes the purchase price reflects an average of trades executed between $14.31 and $14.39 per share, and that the total reported holdings include shares acquired under the company’s dividend reinvestment plan.

Rhea-AI Summary

Hercules Capital, Inc. director Nikos Theodosopoulos reported an open-market purchase of 7,317 shares of common stock on March 26, 2026 at an average price of $14.35 per share. After this transaction, he directly owns 29,362 shares.

According to the footnotes, these shares were acquired based on his election to receive stock instead of a cash director compensation fee, and the reported price reflects an average of trades between $14.31 and $14.39. His total share count also includes shares obtained through the company’s dividend reinvestment plan.

Rhea-AI Summary

Hercules Capital, Inc. Chief Financial Officer Seth H. Meyer reported a small tax-withholding disposition of company stock. On March 5, 2026, 5 shares of common stock were withheld at $15.11 per share to cover taxes on vesting restricted stock, leaving him with 448,548 directly held shares.

Rhea-AI Summary

Hercules Capital, Inc. Chief Operating Officer Christian Follmann reported an open-market purchase of 5,000 shares of common stock on March 4, 2026 at an average price of $14.68 per share. Following this transaction, he directly owns 150,135 shares of Hercules Capital common stock.

The filing also reports 350 shares of common stock held indirectly by his spouse. This amendment corrects an earlier administrative error in how the type of transaction was reported, and restates it as an open-market purchase by the reporting person.

Rhea-AI Summary

Hercules Capital, Inc. Chief Operating Officer Christian Follmann reported an open-market purchase of 5,000 shares of common stock on March 4, 2026 at an average price of $14.68 per share. The filing notes these shares were bought at prices between $14.60 and $14.78.

After this transaction, Follmann directly held 150,135 shares of common stock. The filing also reports 350 shares held indirectly, identified as owned "By Spouse," with the specific transaction direction for that holding not detailed.

Rhea-AI Summary

Hercules Capital director Paramjeet K. Randhawa reported an open-market purchase of 3,050 shares of common stock on March 4, 2026 at $14.78 per share. Following this trade, the director directly owns 19,560 shares, a figure that includes shares acquired through the company’s dividend reinvestment plan.

Rhea-AI Summary

Hercules Capital, Inc. Chief Financial Officer Seth H. Meyer filed an amended insider trading report to correct an administrative error in the number of common shares previously reported as purchased. The amendment confirms his open-market purchase of 14,000 shares at an average price of $14.33 on February 27, 2026, and states that his total beneficial ownership of 448,553 shares was already correctly reported in the original Form 4.

Rhea-AI Summary

Hercules Capital, Inc. director Nikos Theodosopoulos reported an open-market purchase of common stock. He bought 2,600 shares at a price of $14.21 per share. Following this transaction, his directly held stake increased to 21,523 shares of Hercules Capital common stock.

Rhea-AI Summary

Hercules Capital, Inc. director Robert P. Badavas reported an indirect open-market purchase of 5,000 shares of common stock at $14.27 per share through the Robert P. Badavas Trust of 2007. Following this transaction, the trust holds 122,073 shares, and Badavas also reports 1,412 shares held directly.

Rhea-AI Summary

Hercules Capital, Inc. Chief Legal Officer & CCO Kiersten Zaza Botelho bought 1,300 shares of common stock in an open-market purchase at an average price of $14.21 per share. After this transaction, she directly owns 93,336 Hercules Capital common shares.

Rhea-AI Summary

Hercules Capital director Thomas J. Fallon reported an open-market purchase of 20,000 shares of common stock at an average price of $14.20 per share. The filing notes the shares were bought at prices between $14.16 and $14.22 and are held indirectly by the Fallon Family Revocable Trust. Following this transaction, the trust holds 150,369 shares, and Fallon also reports 5,779 shares held directly.

Rhea-AI Summary

Hercules Capital, Inc. Chief Financial Officer Seth H. Meyer reported an open-market purchase of 7,000 shares of common stock. The shares were bought at an average price of $14.33 per share, with trade prices ranging between $14.30 and $14.35. Following this transaction, Meyer directly owns 448,553 shares of Hercules Capital common stock.

Rhea-AI Summary

Hercules Capital, Inc. Chief Executive Officer Scott Bluestein reported an open-market purchase of 7,000 shares of common stock. The average purchase price was $14.35 per share, with trades executed between $14.30 and $14.36. Following this transaction, he directly owns 2,516,379 common shares.

Rhea-AI Summary

Hercules Capital director Wade Loo, through the Loo Revocable Trust, bought 3,300 shares of common stock in an open-market purchase at $14.98 per share. After this indirect purchase, the trust held 32,767 shares, and Loo also held 6,630 shares directly.

Rhea-AI Summary

Hercules Capital, Inc. director Robert P. Badavas reported an open‑market purchase of 5,000 shares of common stock on behalf of the Robert P. Badavas Trust of 2007. The shares were bought at an average purchase price with trades executed between $15.01 and $15.02 per share.

After this transaction, the trust held a total of 117,073 Hercules Capital shares indirectly attributed to Badavas, while he also held 1,412 shares directly. This filing reflects a net increase in his overall reported ownership position in the company.

Rhea-AI Summary

Hercules Capital, Inc. director Thomas J. Fallon reported an indirect open-market purchase of 10,000 shares of common stock at $14.98 per share on February 24, 2026. The shares are held by the Fallon Family Revocable Trust.

After this transaction, the trust holds a total of 130,369 common shares, and Fallon also reports 5,779 common shares held directly. The filing highlights increased indirect ownership through the family trust structure.

Rhea-AI Summary

Hercules Capital, Inc. director Gayle A. Crowell reported an open-market purchase of common stock. On February 23, 2026, Crowell bought 6,600 shares at a price of $15.20 per share. After this transaction, Crowell directly owned 87,458 shares of Hercules Capital common stock. The reported ownership total includes shares previously acquired through the company’s dividend reinvestment plan.

Rhea-AI Summary

Hercules Capital, Inc. Chief Executive Officer Scott Bluestein bought 30,000 shares of common stock in an open-market purchase. The shares were acquired at an average price of $15.08 each, with individual trade prices ranging from $15.04 to $15.10. Following this transaction, Bluestein directly owns 2,509,379 shares of Hercules Capital common stock.

Rhea-AI Summary

Hercules Capital director Nikos Theodosopoulos bought 6,165 shares of common stock in an open-market purchase. The transaction took place on February 17, 2026, at an average price of $15.93 per share. Following this purchase, his directly owned stake increased to 18,923 shares.

Rhea-AI Summary

Hercules Capital, Inc. director Thomas J. Fallon reported an indirect open-market purchase of 20,000 shares of Common Stock on February 17, 2026, at an average price of $15.88 per share. A footnote explains the price reflects purchases between $15.81 and $15.92.

The 20,000 shares are held by the Fallon Family Revocable Trust, bringing its indirect holdings to 120,369 shares. Separately, Fallon directly holds 5,779 shares, which reflects his personal stake outside the trust.

Rhea-AI Summary

Hercules Capital, Inc.'s Chief Financial Officer, Seth H. Meyer, reported share withholding transactions related to restricted stock vesting. On January 9, 2026, 15,965 shares of common stock were withheld at $18.59 per share to cover taxes due on vested restricted stock. On January 11, 2026, an additional 4,052 shares were withheld at $18.59 per share for the same purpose. Following these tax-withholding events, Meyer directly beneficially owned 434,553 shares of Hercules Capital common stock.

Rhea-AI Summary

Hercules Capital, Inc. reported insider equity activity by its Chief Operating Officer, Christian Follmann. The filing shows that on January 9, 2026, and January 11, 2026, a total of 7,580 and 1,178 shares of common stock, respectively, were withheld at a price of $18.59 per share to cover taxes due on vesting restricted stock awards. These are tax-withholding transactions coded as "F," not open-market sales. After these withholdings, Follmann directly beneficially owned 145,134 shares of common stock, and an additional 350 shares were held indirectly by his spouse.

Rhea-AI Summary

Hercules Capital, Inc. insider activity centers on tax withholding for vested stock awards. Chief Legal Officer & CCO Kiersten Zaza Botelho had shares of common stock withheld to cover taxes tied to restricted stock vesting.

On January 9, 2026, 5,510 shares of common stock were withheld at a price of $18.59 per share, leaving her with 92,858 shares beneficially owned directly. On January 11, 2026, an additional 822 shares were withheld at $18.59 per share, resulting in 92,036 shares of common stock held directly after the transactions.

Rhea-AI Summary

Hercules Capital, Inc.'s Chief Executive Officer, Scott Bluestein, reported two automatic share withholdings tied to restricted stock vesting. On January 9, 2026, 50,081 shares of common stock were withheld at $18.59 per share to cover taxes on vested restricted stock. On January 11, 2026, an additional 13,431 shares were withheld at $18.59 per share for the same tax purpose. After these transactions, Bluestein directly owned 2,479,379 shares of Hercules Capital common stock.

Rhea-AI Summary

Hercules Capital, Inc. reported that its Chief Financial Officer, Seth H. Meyer, received a grant of 84,978 shares of common stock on 01/08/2026. The filing lists this as an acquisition at a price of $18.24 per share, bringing his directly owned holdings to 454,570 shares after the transaction.

The shares are described as restricted stock issued under the company’s Amended and Restated Equity Incentive Plan. One-third of this grant is scheduled to vest on the one-year anniversary of the grant date, with the remaining shares vesting quarterly over the following 24 months. These vesting conditions mean the award is tied to continued service over a three-year period.

Rhea-AI Summary

Hercules Capital, Inc. reported an equity award to its Chief Legal Officer and Chief Compliance Officer, Kiersten Zaza Botelho. On 01/08/2026, she acquired 34,265 shares of common stock at $18.24 per share as a grant of restricted stock under the company’s Amended and Restated Equity Incentive Plan. After this grant, she beneficially owns 98,368 common shares directly.

The restricted stock is subject to forfeiture and a multi‑year vesting schedule. One-third of the grant will vest on the one-year anniversary of the grant date, with the remaining shares vesting quarterly over the following 24 months, aligning her compensation with the company’s longer‑term performance.

Rhea-AI Summary

Hercules Capital, Inc. chief operating officer Christian Follmann reported a grant of restricted common stock. On January 8, 2026, he acquired 37,007 shares of common stock at $18.24 per share. These shares were issued under the company’s Amended and Restated Equity Incentive Plan and are subject to forfeiture restrictions, with one-third vesting on the one-year anniversary of the grant date and the remainder vesting quarterly over the following 24 months.

After this grant, Follmann beneficially owns 153,892 shares of common stock directly, plus 350 shares held indirectly through his spouse.

Rhea-AI Summary

Hercules Capital, Inc. reported an insider equity award for its Chief Executive Officer, Scott Bluestein. On 01/08/2026, he received 298,794 shares of common stock as a restricted stock grant at $18.24 per share under the company’s Amended and Restated Equity Incentive Plan. These shares are subject to forfeiture and vest over time, with one-third vesting on the one-year anniversary of the grant date and the remaining two-thirds vesting quarterly over the following 24 months.

Following this grant, Bluestein directly beneficially owns 2,542,891 shares of Hercules Capital common stock, aligning his compensation further with shareholder interests through performance- and tenure-based vesting.

Rhea-AI Summary

Hercules Capital, Inc. reported an equity compensation grant to a senior executive. Chief Operating Officer Christian Follmann received an award of 10,560 restricted stock units on December 4, 2025. Each restricted stock unit gives him the right to receive one share of Hercules Capital common stock in the future. The award is scheduled to vest 100% on December 4, 2032, meaning all units become payable on that date if vesting conditions are met. Following this grant, Follmann beneficially owned 39,448 derivative securities, all held directly.

Rhea-AI Summary

Hercules Capital, Inc. reported that its Chief Legal Officer and Chief Compliance Officer, Kiersten Zaza Botelho, received an award of 10,560 restricted stock units (RSUs) on December 4, 2025. Each RSU represents a contingent right to receive one share of Hercules Capital common stock. According to the disclosure, this RSU grant will vest 100% on December 4, 2032, meaning the shares underlying the units are not delivered until that future vesting date, assuming conditions are met. The filing is made by a single reporting person and reflects an equity-based compensation award rather than an open-market stock purchase or sale.

Rhea-AI Summary

Hercules Capital, Inc. reported an insider equity transaction by its Chief Financial Officer on a Form 4. On December 4, 2025, the CFO received an award of 7,920 restricted stock units (RSUs), each representing one share of common stock, which will vest 100% on December 4, 2032. On December 5, 2025, 20 shares of common stock were withheld at a price of $0.00 to cover taxes related to restricted stock vesting. Following these transactions, the CFO beneficially owns 369,592 shares of common stock and 45,184 RSUs, all held directly.